# Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use Disorders

> **NCT00237822** · PHASE2 · COMPLETED · sponsor: **Yale University** · enrollment: 75 (estimated)

## Conditions studied

- Diagnosis, Dual (Psychiatry)
- Psychiatric Diagnosis
- Drug Use Disorders

## Interventions

- **BEHAVIORAL:** Adherence Feedback (AF)
- **BEHAVIORAL:** AF + Contingency Management (AF + CM)
- **BEHAVIORAL:** AF + Motivational Enhancement Therapy (AF + MET)

## Key facts

- **NCT ID:** NCT00237822
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2017-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00237822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00237822, "Increasing Treatment Adherence in Co-Occurring Psychiatric and Drug Use Disorders". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00237822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*